Keywords: Oncodesign, Sanofi, Nannocyclix technology, Kinase target programs

Oncodesign in up to 130 million-euro deal with Sanofi

Article | 14 September 2012

Oncodesign, a Dijon, France-based drug discovery company and oncology pharmacology service provider, has entered into a strategic research collaboration with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Oncodesign

Sanofi

Go to company listing